Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1901 - Similarities and Differences in Immune Modulation by Acalabrutinib and Zanubrutinib in Chronic Lymphocytic Leukemia

    Primary Author / Presenter(s)

  • MA

    Maria L. Andersson, MD, PhD student

    Resident physician, PhD student
    Department of Oncology-Pathology, Karolinska Institutet; Department of Hematology, Karolinska University Hospital
    Stockholm, Stockholms Lan, Sweden

    • Co-Author(s)

  • OL

    Olina Lind, MSc

    PhD student
    Department of Oncology-Pathology, Karolinska Institutet
    Stockholm, Stockholms Lan, Sweden

  • KH

    Kia Heimersson, Biomedical laboratory scientist

    BMA
    Department of Oncology-Pathology, Karolinska Institutet
    Stockholm, Stockholms Lan, Sweden

  • AB

    Anna Berglof, PhD

    Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine, Karolinska Institutet
    Stockholm, Stockholms Lan, Sweden

  • Td

    Teresa del Peso Santos, PhD

    Department of Molecular Medicine and Surgery, Karolinska Institutet; Centre for Inherited Metabolic Diseases, Karolinska University Hospital
    Stockholm, Stockholms Lan, Sweden

  • LP

    Lucía Peña-Pérez, PhD

    Department of Molecular Medicine and Surgery, Karolinska Institutet; Centre for Inherited Metabolic Diseases, Karolinska University Hospital
    Stockholm, Stockholms Lan, Sweden

  • QW

    Qing Wang

    Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine, Karolinska Institutet
    Stockholm, Stockholms Lan, Sweden

  • TM

    Tom Mulder, MD, PhD

    Department of Oncology-Pathology, Karolinska Institutet; Department of Hematology, Karolinska University Hospital
    Stockholm, Sweden

  • RZ

    Rula Zain, PhD

    Assoc prof
    Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine, Karolinska Institutet; Karolinska ATMP Center, Karolinska Institutet, Karolinska University Hospital; Centre for Rare Diseases, Department of Clinical Genetics and Genomics, Karolinska University Hospital
    Stockholm, Stockholms Lan, Sweden

  • RM

    Robert MÃ¥nsson, PhD

    Department of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet
    Stockholm, Stockholms Lan, Sweden

  • Richard Rosenquist, MD, PhD

    Professor
    Department of Molecular Medicine and Surgery, Karolinska Institutet; Clinical Genetics and Genomics, Karolinska University Hospital
    Karolinska Institutet
    Stockholm, Stockholms Lan, Sweden

  • CS

    C. I. Edvard Smith, PhD

    Professor, senior researcher
    Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine, Karolinska Institutet; Karolinska ATMP Center, Karolinska Institutet, Karolinska University Hospital
    Stockholm, Stockholms Lan, Sweden

  • AÃ

    Anders Österborg, MD, PhD

    Department of Oncology-Pathology, Karolinska Institutet; Department of Hematology, Karolinska University Hospital
    Stockholm, Stockholms Lan, Sweden

  • MP

    Marzia Palma, MD, PhD

    Senior consultant
    Department of Oncology-Pathology, Karolinska Institutet; Department of Hematology, Karolinska University Hospital
    Stockholm, Stockholms Lan, Sweden